The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...

These Illinois restaurants turn every meal into an experience, with creative menus, vibrant settings, and moments you won’t ...

US fusion firm Commonwealth Fusion Systems (CFS) has announced partnerships with Nvidia and Siemens to develop a digital twin ...

Electricity has always been central to how life works, from the firing of neurons to the beating of the heart, but new ...

In a world of constant notifications and digital demands, Exeter, New Hampshire stands as a refreshing counterpoint – a place where historic architecture, tree-lined streets, and genuine community ...

Cherryvale, Kansas sits quietly in Montgomery County, a small town that’s mastered the art of living well without the big-city price tag or the big-city headaches. Ever notice how retirement brochures ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

A component of the complement system promotes tumor growth by activating myeloid-derived suppressor cells. Figure 1: Multiple pro-inflammatory mediators in the tumor microenvironment increase the ...

The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...